This topic contains a solution. Click here to go to the answer

Author Question: A repeated-measures analysis of variance differs from a one-way and a factorial design because a. ... (Read 69 times)

leo leo

  • Hero Member
  • *****
  • Posts: 566
A repeated-measures analysis of variance differs from a one-way and a factorial design because
 
  a. the measures in a repeated-measures design are correlated.
  b. the measures in a standard factorial are independent.
  c. the measures in a repeated-measures design are not independent from time to time.
  d. all of the above

Question 2

The analysis of variance differs from a t test for two independent samples because
 
  a. the t test is limited to 2 samples.
  b. the analysis of variance can handle multiple samples.
  c. they test different hypotheses.
  d. both a and b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macmac

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

D

Answer to Question 2

D




leo leo

  • Member
  • Posts: 566
Reply 2 on: Jun 20, 2018
Gracias!


jamesnevil303

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

For a complete list of videos, visit our video library